Evidence map›Paper›PMID 33103819›Full record

Trial reportAlzheimer's & dementia : the journal of the Alzheimer's Association2021

A ketogenic drink improves cognition in mild cognitive impairment: Results of a 6-month RCT.

Mélanie Fortier, Christian-Alexandre Castellano, Valérie St-Pierre, Étienne Myette-Côté, Francis Langlois, Maggie Roy, Marie-Christine Morin, Christian Bocti, Tamas Fulop, Jean-Philippe Godin and 3 more

4 registry-linked trialsOpen access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 114 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
114citing papers in PubMed, 8 pooled it
11.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05469997 nacompletednot on this mapstarted 2023, after this paper: background citation

Ketogenic Diet Interventions in Parkinson's Disease: Safeguarding the Gut Microbiome

TypeinterventionalSponsorUniversity of British ColumbiaRan2023 to 2024Enrolled52ConditionsParkinson DiseaseArmsMediterranean-Ketogenic Diet, Mediterranean diet supplemented with medium-chain triglyceride oil
NCT06651112 not yet recruitingnot on this mapstarted 2024, after this paper: background citation

Impacts of Psychosis and Antipsychotics on Cerebral Energy Metabolism: the ATP Project (Antipsychotic-TEP-Psychosis)

TypeobservationalSponsorUniversité de SherbrookeRan2024 to 2027Enrolled18ConditionsFirst Episose Psychosis, Metabolic Disease, Psychosis, EpisodeArmsAntipsychotic drugs
NCT07021664 not yet recruitingnot on this mapstarted 2025, after this paper: background citation

Santé, Imagerie et Cognition à Travers la Transition ménopausique

TypeobservationalSponsorUniversité de SherbrookeRan2025 to 2026Enrolled45ConditionsMenopause
NCT07364162 phase2recruitingnot on this mapstarted 2026, after this paper: background citation

Exogenous Ketone Ester Supplementation in ICU Delirium (KETONES ICU)

TypeinterventionalSponsorVanderbilt University Medical CenterRan2026 to 2027Enrolled40ConditionsICU Delirium, Critical IllnessArmsKetone monoester, Placebo
3 · Its place in the literature

Who cites it

114 citing papers in PubMed, 8 syntheses or guidelines pooled it, 169 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. A ketogenic drink improves cognition in mild cognitive impairment: Results of a 6-month RCT.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2021
    Trial
  14. Trial
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review

54 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Mélanie FortierResearch Center on Aging, CIUSSS de l'Estrie-CHUS, Sherbrooke, Quebec, Canada.
Christian-Alexandre CastellanoResearch Center on Aging, CIUSSS de l'Estrie-CHUS, Sherbrooke, Quebec, Canada.
Valérie St-PierreResearch Center on Aging, CIUSSS de l'Estrie-CHUS, Sherbrooke, Quebec, Canada.
Étienne Myette-CôtéResearch Center on Aging, CIUSSS de l'Estrie-CHUS, Sherbrooke, Quebec, Canada.
Francis LangloisCIUSSS de l'Éstrie-CHUS, Sherbrooke, Quebec, Canada.
Maggie RoyResearch Center on Aging, CIUSSS de l'Estrie-CHUS, Sherbrooke, Quebec, Canada.
Marie-Christine MorinResearch Center on Aging, CIUSSS de l'Estrie-CHUS, Sherbrooke, Quebec, Canada.
Christian BoctiResearch Center on Aging, CIUSSS de l'Estrie-CHUS, Sherbrooke, Quebec, Canada.
Tamas FulopResearch Center on Aging, CIUSSS de l'Estrie-CHUS, Sherbrooke, Quebec, Canada.
Jean-Philippe GodinInstitute of Food Safety and Analytical Sciences, Nestlé Research, Lausanne, Switzerland.
Carla DelannoyNestlé Health Sciences, Lausanne, Switzerland.
Bernard CuenoudNestlé Health Sciences, Lausanne, Switzerland.
Stephen C CunnaneResearch Center on Aging, CIUSSS de l'Estrie-CHUS, Sherbrooke, Quebec, Canada.
Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal · CAUniversité de Sherbrooke · CANestlé (Switzerland) · CHCentre Hospitalier Universitaire de Sherbrooke · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionCounteracting impaired brain glucose metabolism with ketones may improve cognition in mild cognitive impairment (MCI).

methodsCognition, plasma ketone response, and metabolic profile were assessed before and 6 months after supplementation with a ketogenic drink containing medium chain triglyceride (ketogenic medium chain triglyceride [kMCT]; 15 g twice/day; n = 39) or placebo (n = 44).

resultsFree and cued recall (Trial 1; P = .047), verbal fluency (categories; P = .024), Boston Naming Test (total correct answers; P = .033), and the Trail-Making Test (total errors; P = .017) improved significantly in the kMCT group compared to placebo (analysis of covariance; pre-intervention score, sex, age, education, and apolipoprotein E4 as covariates). Some cognitive outcomes also correlated positively with plasma ketones. Plasma metabolic profile and ketone response were unchanged.

conclusionsThis kMCT drink improved cognitive outcomes in MCI, at least in part by increasing blood ketone level. These data support further assessment of MCI progression to Alzheimer's disease.

Indexed as

BeveragesDiet, KetogenicAgedCognitionCognitive DysfunctionFemaleHumansKetonesMaleNeuropsychological TestsTriglyceridesKetonesTriglyceridesacetoacetateAlzheimer's diseasebeta-hydroxybutyratecognitionepisodic memoryexecutive functionketonelanguagemedium chain triglyceridemild cognitive impairment

Identifiers

PMID33103819
PMCPMC8048678
OpenAlexW3094607082

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.